Observatoire des droits humains (anglais seulement)

New Tool Calculates Cost-Benefit Analysis for Cancer Treatments

(Version anglaise seulement)

As options for cancer patients become increasingly complicated, and expensive, the most influential source for U.S. oncology treatment guidelines will for the first time offer a tool to assess the costs versus benefits of available therapies. The National Comprehensive Cancer Network (NCCN) says its new tool will provide a clearer picture of the relative value of medication options, particularly in cases where a very expensive therapy does little to improve survival. Doctors developing...

Lire l'article complet